Abiopharma

(99% Neutral) NANOVIBRONIX, INC. (FEED) Files Form 8-K

(99% Neutral) CENCORA, INC. (COR) Announces New Board Appointment

(30% Negative) QUOIN PHARMACEUTICALS, LTD. (QNRX) Reports Q3 2026 Financial Results

- Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

(99% Neutral) NEWAMSTERDAM PHARMA CO N.V. (NAMSW) Announces New Board Appointment

Japan Post Holdings Co., Ltd. 🔴 sold 12.8K shares of AFLAC INC (AFL) at $121.29 ($1.5M) Transaction Date: Aug 12, 2026 | Filing ID: 097088

Leproust Emily M. 🟡 adjusted position in 20.0K shares (5 derivative) of Twist Bioscience Corp (TWST) at $125.08 ($3.6M) Transaction Date: Aug 12, 2026 | Filing ID: 010403

Lorig Brian 🔴 sold 59.6K shares of KLA CORP (KLAC) at $208.13 ($12.4M) Transaction Date: Aug 13, 2026 | Filing ID: 352187

Cue Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Ebang International Holdings Inc. Announces Unaudited Financial Results for the First Half of Fiscal Year 2026

4DMT Announces New Employment Inducement Grants

1847 Holdings Reports Second Quarter 2026 Financial Results and Provides Update on CMD Sale Process

Invesco Mortgage Capital Inc. August 2026 Dividend Announcement and July Financial Update

LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update

Lattice Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)